ROPHARMA SA reported earnings results for the nine months of 2016. For the period, the company reported net sales revenue of RON 350,473,087, total operating income of RON 353,278,647, operating results of RON 6,353,469, net financial loss of RON 127,959, profit before tax of RON 6,225,510 and net income of RON 4,973,112 against net sales revenue of RON 333,713,754 total operating income of RON 335,732,248, operating results of RON 7,416,499, net financial results of RON 46,987, profit before tax of RON 7,463,486 and net income of RON 6,005,792 for the same period a year ago. EBITDA was RON 11,209,815 against RON 12,159,795 for the same period a year ago. EBIT was RON 7,416,499 against RON 6,353,469 for the same period a year ago.